Partnership advances development of novel therapies targeting cancer treatment....
Designation supports development of innovative treatment for nontuberculous mycobacterial infections....
Simplifying the Process for Exercising Publicly-Traded Warrants to Maximize Investor Participation....
New application highlights advancements in nasal protection and drug delivery solutions....
Company achieves major milestones, advancing its robotic surgical system toward market launch....
New formulation enhances delivery options for advanced cancer treatments. ...
Accelerating global expansion with cutting-edge technology targeting multiple sclerosis, a prevalent condition in North America and Europe...
The next-gen Anovo® system, featuring groundbreaking haptic feedback and multi-directional flexibility, enhances surgeon precision and expands the reach of robotic-assisted procedures in gynecology and beyond....
For the treatment of Atrial Fibrillation...
To support access to newly approved innovative technologies...
